Fig. 1From: Intracellular hypoxia measured by 18F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancerTumor 18F-fluoromisonidazole uptake and intrinsic subtypes. TBR Tissue-to-blood ratio, HER2 Human epidermal growth factor receptor 2, TNBC Triple-negative breast cancerBack to article page